285 related articles for article (PubMed ID: 35933030)
1. Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice.
Wang Y; Wernersbach I; Strehle J; Li S; Appel D; Klein M; Ritter K; Hummel R; Tegeder I; Schäfer MKE
Brain Behav Immun; 2022 Nov; 106():49-66. PubMed ID: 35933030
[TBL] [Abstract][Full Text] [Related]
2. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
[TBL] [Abstract][Full Text] [Related]
3. Traumatic Brain Injury Causes Chronic Cortical Inflammation and Neuronal Dysfunction Mediated by Microglia.
Witcher KG; Bray CE; Chunchai T; Zhao F; O'Neil SM; Gordillo AJ; Campbell WA; McKim DB; Liu X; Dziabis JE; Quan N; Eiferman DS; Fischer AJ; Kokiko-Cochran ON; Askwith C; Godbout JP
J Neurosci; 2021 Feb; 41(7):1597-1616. PubMed ID: 33452227
[TBL] [Abstract][Full Text] [Related]
4. Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model.
Tahmasebi F; Pasbakhsh P; Mortezaee K; Madadi S; Barati S; Kashani IR
J Cell Biochem; 2019 Jun; 120(6):10576-10586. PubMed ID: 30628737
[TBL] [Abstract][Full Text] [Related]
5. Chronic Cortical Inflammation, Cognitive Impairment, and Immune Reactivity Associated with Diffuse Brain Injury Are Ameliorated by Forced Turnover of Microglia.
Bray CE; Witcher KG; Adekunle-Adegbite D; Ouvina M; Witzel M; Hans E; Tapp ZM; Packer J; Goodman E; Zhao F; Chunchai T; O'Neil S; Chattipakorn SC; Sheridan J; Kokiko-Cochran ON; Askwith C; Godbout JP
J Neurosci; 2022 May; 42(20):4215-4228. PubMed ID: 35440489
[TBL] [Abstract][Full Text] [Related]
6. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
Uyar O; Laflamme N; Piret J; Venable MC; Carbonneau J; Zarrouk K; Rivest S; Boivin G
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938766
[TBL] [Abstract][Full Text] [Related]
7. Minocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
Li X; Hu B; Guan X; Wang Z; Zhou Y; Sun H; Zhang X; Li Y; Huang X; Zhao Y; Wang X; Xu H; Zhang YW; Wang Z; Zheng H
J Neuroinflammation; 2023 May; 20(1):134. PubMed ID: 37259140
[TBL] [Abstract][Full Text] [Related]
8. Partial reduction of microglia does not affect tau pathology in aged mice.
Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.
Liu Y; Given KS; Dickson EL; Owens GP; Macklin WB; Bennett JL
Exp Neurol; 2019 Aug; 318():32-41. PubMed ID: 31029597
[TBL] [Abstract][Full Text] [Related]
10. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in microglia in the mouse hippocampus during administration and withdrawal of the CSF1R inhibitor PLX3397.
Wang Q; Wang YY; Pu WJ; Ma X; Ni RJ
J Anat; 2023 Sep; 243(3):394-403. PubMed ID: 37038887
[TBL] [Abstract][Full Text] [Related]
12. Cognitive deficits develop 1month after diffuse brain injury and are exaggerated by microglia-associated reactivity to peripheral immune challenge.
Muccigrosso MM; Ford J; Benner B; Moussa D; Burnsides C; Fenn AM; Popovich PG; Lifshitz J; Walker FR; Eiferman DS; Godbout JP
Brain Behav Immun; 2016 May; 54():95-109. PubMed ID: 26774527
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CSF1R, a receptor involved in microglia viability, alters behavioral and molecular changes induced by cocaine.
da Silva MCM; Gomes GF; de Barros Fernandes H; da Silva AM; Teixeira AL; Moreira FA; de Miranda AS; de Oliveira ACP
Sci Rep; 2021 Aug; 11(1):15989. PubMed ID: 34362959
[TBL] [Abstract][Full Text] [Related]
14. Elimination of Microglia Improves Functional Outcomes Following Extensive Neuronal Loss in the Hippocampus.
Rice RA; Spangenberg EE; Yamate-Morgan H; Lee RJ; Arora RP; Hernandez MX; Tenner AJ; West BL; Green KN
J Neurosci; 2015 Jul; 35(27):9977-89. PubMed ID: 26156998
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells.
Okojie AK; Uweru JO; Coburn MA; Li S; Cao-Dao VD; Eyo UB
J Neuroinflammation; 2023 Oct; 20(1):242. PubMed ID: 37865779
[TBL] [Abstract][Full Text] [Related]
16. PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).
Horti AG; Naik R; Foss CA; Minn I; Misheneva V; Du Y; Wang Y; Mathews WB; Wu Y; Hall A; LaCourse C; Ahn HH; Nam H; Lesniak WG; Valentine H; Pletnikova O; Troncoso JC; Smith MD; Calabresi PA; Savonenko AV; Dannals RF; Pletnikov MV; Pomper MG
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1686-1691. PubMed ID: 30635412
[TBL] [Abstract][Full Text] [Related]
17. Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice.
Elmore MRP; Hohsfield LA; Kramár EA; Soreq L; Lee RJ; Pham ST; Najafi AR; Spangenberg EE; Wood MA; West BL; Green KN
Aging Cell; 2018 Dec; 17(6):e12832. PubMed ID: 30276955
[TBL] [Abstract][Full Text] [Related]
18. A limited capacity for microglial repopulation in the adult brain.
Najafi AR; Crapser J; Jiang S; Ng W; Mortazavi A; West BL; Green KN
Glia; 2018 Nov; 66(11):2385-2396. PubMed ID: 30370589
[TBL] [Abstract][Full Text] [Related]
19. The CSF1-CSF1R pathway in the trigeminal ganglion mediates trigeminal neuralgia via inflammatory responses in mice.
He Z; Xu C; Guo J; Liu T; Zhang Y; Feng Y
Mol Biol Rep; 2024 Jan; 51(1):215. PubMed ID: 38281257
[TBL] [Abstract][Full Text] [Related]
20. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
Butowski N; Colman H; De Groot JF; Omuro AM; Nayak L; Wen PY; Cloughesy TF; Marimuthu A; Haidar S; Perry A; Huse J; Phillips J; West BL; Nolop KB; Hsu HH; Ligon KL; Molinaro AM; Prados M
Neuro Oncol; 2016 Apr; 18(4):557-64. PubMed ID: 26449250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
